Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) has reported record financial results for the fourth quarter and fiscal 2022 as it expanded its product portfolio.
Valeo Pharma Reports Record Quarterly and Annual Revenues for the Fourth Quarter and the Fiscal Year 2022 investorintel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorintel.com Daily Mail and Mail on Sunday newspapers.
Valeo Pharma Inc says Health Canada has accepted for review Veru's New Drug Submission for sabizbulin proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
/CNW Telbec/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, announced today that it.